Status:
COMPLETED
The Norwegian Adult Achondroplasia Study
Lead Sponsor:
Sunnaas Rehabilitation Hospital
Conditions:
Achondroplasia
Eligibility:
All Genders
16+ years
Brief Summary
The study aims to investigate the Norwegian adult achondroplasia population regarding degree and extent of symptoms and clinical manifestations and how this population manages in daily life, including...
Detailed Description
The present study aims to investigate the degree and extent of spinal stenosis, chronic pain, sleep apnoea, impaired hearing, cardiovascular risk factors and body composition in Norwegian adults with ...
Eligibility Criteria
Inclusion
- Residents of Norway
- Aged 16 years or older
- Clinical and genetic diagnosis of achondroplasia
- Speak and understand the Norwegian language.
Exclusion
- Severe cognitive deficits, mental illness or substance abuse
- Having a medical condition making them unable to participate in the study.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03780153
Start Date
March 1 2017
End Date
March 21 2022
Last Update
October 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnas Rehabilitation Hospital
Nesoddtangen, Akershus, Norway, 1450